CD73-IN-1
CAS No. 2132396-40-6
CD73-IN-1( —— )
Catalog No. M32829 CAS No. 2132396-40-6
CD73-IN-1 is a CD73 inhibitor with anticancer activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 135 | Get Quote |
|
| 5MG | 225 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCD73-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionCD73-IN-1 is a CD73 inhibitor with anticancer activity.
-
DescriptionCD73-IN-1 is an inhibitor of CD73 which can be used in the treatment of cancer extracted from patent WO 2017153952 A1, example 80.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorCD73
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2132396-40-6
-
Formula Weight371.41
-
Molecular FormulaC18H17N3O4S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 150 mg/mL (403.87 mM)
-
SMILESNC(=O)c1cc(ccc1O)S(=O)(=O)Nc1ccc2cc([nH]c2c1)C1CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Jerry Leroy Adams, et al. 5-sulfamoyl-2-hydroxybenzamide derivatives. WO 2017153952 A1.
molnova catalog
related products
-
Neuropeptide Y-Lys(B...
Neuropeptide Y-Lys(Biotin), human, rat; NPY-Lys(Biotin), human, rat
-
Ticarcillin disodium
Ticarcillin disodium is an injectable antibiotic for the treatment of Gram-negative bacteria, particularly Pseudomonas aeruginosa.
-
DS-1040
DS-1040 (DS1040)?is a small molecule inhibitor of the activated thrombin-activatable fibrinolysis inhibitor (TAFIa) with IC50 of 1.7 ng/mL for rabbit TAFIa.
Cart
sales@molnova.com